Vericel Corp

VCELNASDAQ · USD
40.02USD-0.01 (-0.03%)
699

Vericel Corp (VCEL) Implied Volatility Current

VCEL implied volatility is 56%. IV Rank is 12%, placing current premiums in the bottom of their 52-week range.

Read more

Tracking VCEL implied volatility helps you identify when options premiums on Vericel Corp are historically cheap or expensive, and where the best trades are hiding. Vericel Corp implied volatility reflects the market's expectation of future price movement: when VCEL IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Vericel Corp's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For VCEL, tracking metrics like VCEL IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on VCEL signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns.

The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where VCEL implied volatility sits today versus where it has been. Our scanner ranks Vericel Corp implied volatility against its historical range, surfaces extremes in VCEL IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Vericel Corp IV is rich or cheap — measure it, then act on it.

Implied Volatility

IV Rank
11.51%IV Rank
Low

IV is compressed vs the past year - options are relatively cheap, favoring buyers.

Implied Volatility (30d)55.75%

IV Rank11.51%

Historical Volatility (30d)27.33%

IV - HV+28.42%

As of September 17, 2026

Trade options with IV on your side

Track VCEL IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.

Start your 14-day free trial